Featured 13F manager
DME Capital Management David Einhorn
New York, NY 20 processed 13Fs on this site · 2021 Q3–2026 Q2
- $3.9B
- 46 holds
- 2026 Q2
- +22.5% QoQ
- Top 5 38.2%
David Einhorn files DME Capital Management as a Form 13F. The latest book is 2026 Q2 at $3.9B, up 22.5% QoQ, led by Green Brick Partners, Fluor, and Core Natural Resources.
Portfolio
top 5 38.2% · top 10 52.8%
- GRBK - Green Brick Partners 19.4%
- FLR - Fluor 6.2%
- CNR - Core Natural Resources 4.7%
- BHF - Brighthouse Finl 4.6%
- ACHC — 3.3%
- PENN - Penn Entertainment 3.2%
- FBIN - Fortune Brands 3.1%
- PCG - Pg And E 2.9%
- CNC - Centene Del 2.7%
- PKG - Graphic Packaging 2.7%
- SNX - Td Synnex 2.6%
- TEVA - Teva Pharmaceutical Inds 2.5%
- Other 42.1%
AUM over time
Book
| GRBK - Green Brick Partners | Hold | 9,467,383 | $73.86 | $699M | — | — | |
| FLR - Fluor | Add +44.4% | 5,513,680 | $42.07 | $232M | +1,694,100 | +$36M | |
| CNR - Core Natural Resources | Hold | 2,155,640 | $83.48 | $180M | — | — | |
| BHF - Brighthouse Finl | Add +1.2% | 2,792,100 | $53.08 | $148M | +32,003 | −$206K | |
| KD - Kyndryl | Add +31.2% | 4,343,627 | $30.03 | $130M | +1,032,330 | −$9M | |
| PENN - Penn Entertainment | Reduce −9.7% | 6,769,440 | $19.26 | $130M | −725,000 | −$4M | |
| PCG - Pg And E | New | 6,380,853 | $15.08 | $96M | +6,380,853 | +$96M | |
| PKG - Graphic Packaging | Hold | 4,705,950 | $19.57 | $92M | — | — | |
| DHT — | Hold | 7,620,934 | $11.95 | $91M | — | — | |
| TEVA - Teva Pharmaceutical Inds | Hold | 3,778,777 | $20.20 | $76M | — | — | |
| WFRD - Weatherford Intl | Hold | 960,810 | $68.43 | $66M | — | — | |
| CNH - Cnh Indl | Reduce −25.0% | 5,904,460 | $10.85 | $64M | −1,968,150 | −$38M | |
| GLD - Spdr Gold Tr | Add +3.4% | 175,101 | $355.47 | $62M | +5,690 | +$11M | |
| LBTYA - Liberty Global · CL A | Hold | 5,220,502 | $11.46 | $60M | — | — | |
| CNC - Centene Del | Add +86.0% | 1,560,540 | $35.68 | $56M | +721,370 | +$10M | |
| CPRI - Capri | Reduce −22.8% | 2,687,597 | $19.92 | $54M | −791,510 | −$8M | |
| VSXY - Victorias Secret And | Add +117.7% | 1,932,462 | $27.14 | $52M | +1,044,712 | +$36M | |
| SDRL - Seadrill | Hold | 1,588,828 | $30.21 | $48M | — | — | |
| ACHC — | Add +89.9% | 1,642,710 | $24.76 | $41M | +777,699 | +$21M | |
| ROIV - Roivant Sciences | Reduce −50.0% | 2,275,529 | $15.13 | $34M | −2,275,528 | −$17M | |
| CI - The Cigna Group | Hold | 93,750 | $288.25 | $27M | — | — | |
| United Parks & Resorts | New | 471,050 | $51.70 | $24M | +471,050 | +$24M | |
| LKFT - Galapagos | Hold | 482,746 | $34.64 | $17M | — | — | |
| Nexstar Media Group | New | 73,940 | $197.74 | $15M | +73,940 | +$15M | |
| COYA - Coya Therapeutics | Hold | 1,646,440 | $5.70 | $9M | — | — | |
| HPQ - HP | Reduce −90.1% | 300,000 | $27.23 | $8M | −2,718,770 | −$66M | |
| SNX - Td Synnex | Add +17.3% | 39,030 | $163.75 | $6M | +5,760 | +$2M | |
| GDX - Vaneck ETF Trust | Hold | 76,460 | $76.40 | $6M | — | — | |
| KWEB - Kraneshares Trust | New | 86,370 | $42.01 | $4M | +86,370 | +$4M | |
| GPRO - Gopro · CL A | Reduce −40.0% | 1,693,860 | $2.12 | $4M | −1,129,240 | +$1M | |
| OIH - Vaneck ETF Trust | Reduce −22.5% | 12,360 | $259.91 | $3M | −3,580 | −$458K | |
| SHC - Sotera Health | Reduce −22.7% | 180,580 | $15.73 | $3M | −53,110 | +$242K | |
| PTON - Peloton Interactive · CL A | Add +37.3% | 246,460 | $9.00 | $2M | +66,990 | +$973K | |
| GANX - Gain Therapeutics | Hold | 566,130 | $1.77 | $1M | — | — | |
| NUVB - Nuvation Bio · CL A | Hold | 34,995 | $3.70 | $129K | — | — |
Exits / last held
Not current holdings · last reported size, unchanged · gone vs 2025 Q2
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| TECK - Teck Resources · CL B | Exit | 0 | $40.38 | $81M | −2,000,000 | −$81M |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 46 | $3.9B | +22.5% | 13F-HR | 8/14/2026 | 000117266126003786 |
| 2026 Q1 | 45 | $3.2B | +12.0% | 13F-HR | 5/15/2026 | 000117266126002341 |
| 2025 Q4 | 41 | $2.8B | +12.1% | 13F-HR | 2/17/2026 | 000117266126001122 |
| 2025 Q3 | 37 | $2.5B | +9.3% | 13F-HR | 11/14/2025 | 000117266125005032 |
| 2025 Q2 | 34 | $2.3B | +17.8% | 13F-HR | 8/14/2025 | 000117266125003351 |
| 2025 Q1 | 33 | $2B | +1.5% | 13F-HR | 5/15/2025 | 000117266125002307 |
| 2024 Q4 | 36 | $1.9B | −19.1% | 13F-HR | 2/14/2025 | 000117266125001165 |
| 2024 Q3 | 38 | $2.4B | +17.6% | 13F-HR | 11/14/2024 | 000117266124005240 |
| 2024 Q2 | 39 | $2B | −6.5% | 13F-HR | 8/14/2024 | 000117266124003549 |
| 2024 Q1 | 42 | $2.2B | — | 13F-HR | 5/15/2024 | 000117266124002489 |
| 2023 Q4 | 40 | $2B | +16.3% | 13F-HR | 2/14/2024 | 000117266124001512 |
| 2023 Q3 | 39 | $1.8B | −17.4% | 13F-HR | 11/14/2023 | 000117266123004012 |
| 2023 Q2 | 41 | $2.1B | +15.9% | 13F-HR | 8/14/2023 | 000117266123003174 |
| 2023 Q1 | 39 | $1.8B | +27.4% | 13F-HR | 5/15/2023 | 000117266123002282 |
| 2022 Q4 | 42 | $1.4B | +2.3% | 13F-HR | 2/14/2023 | 000117266123001336 |
| 2022 Q3 | 42 | $1.4B | +9.8% | 13F-HR | 11/14/2022 | 000117266122002565 |
| 2022 Q2 | 47 | $1.3B | −18.3% | 13F-HR | 8/15/2022 | 000117266122002019 |
| 2022 Q1 | 52 | $1.6B | −10.0% | 13F-HR | 5/16/2022 | 000117266122001474 |
| 2021 Q4 | 57 | $1.7B | +17.2% | 13F-HR | 2/14/2022 | 000117266122000884 |
| 2021 Q3 | 58 | $1.5B | — | 13F-HR | 11/15/2021 | 000117266121002370 |
About
DME Capital Management
20 processed 13Fs on this site · 2021 Q3–2026 Q2